Leqvio vs. Livalo
See how Leqvio and Livalo compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Leqvio is a twice-yearly injection that silences PCSK9 production in the liver, while Livalo is a daily statin pill that blocks cholesterol synthesis directly.
Both drugs lower LDL cholesterol, but Leqvio must be injected by a healthcare provider and Livalo is a tablet patients take at home on their own.
Livalo has more than a decade of statin safety data and a lower monthly price, while Leqvio offers far less frequent dosing but no generic option.
Leqvio vs. Livalo Drug Summary
Leqvio
Leqvio (inclisiran) is a PCSK9 synthesis inhibitor given as a subcutaneous injection to lower LDL cholesterol in adults with high cholesterol or certain inherited forms of high cholesterol. After two starting doses, it only needs to be injected twice a year by a healthcare provider.
Livalo
Livalo (pitavastatin) is a statin that blocks an enzyme in the liver needed to make cholesterol, lowering LDL, total cholesterol, and triglycerides. It comes as a tablet taken once a day, usually starting at a low dose that can be adjusted based on response.
Leqvio vs. Livalo Side Effects
Leqvio
Livalo
Leqvio vs. Livalo Dosage
Leqvio
Livalo
| STAGE | DOSE | WHEN |
| Starting dose | 284 mg injection | Day 1 |
| Maximum dose | 284 mg injection | Same as starting |
| Dose changes | None | Fixed dose |
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 4 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Leqvio
| STAGE | DOSE | WHEN |
| Starting dose | 284 mg injection | Day 1 |
| Maximum dose | 284 mg injection | Same as starting |
| Dose changes | None | Fixed dose |
Livalo
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 4 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Leqvio vs. Livalo Indications
Leqvio
Leqvio is FDA-approved as an add-on to diet and exercise to lower LDL cholesterol in adults with high cholesterol, including those with heterozygous familial hypercholesterolemia. It is also approved for patients 12 and older with heterozygous or homozygous familial hypercholesterolemia. It is not approved as a stand-alone treatment for acute cardiovascular events.
Adults with primary hyperlipidemia
Adults and teens 12+ with heterozygous FH
Teens 12+ with homozygous FH
Used alongside diet and exercise, not alone
Livalo
Livalo is FDA-approved as an add-on to diet to lower LDL cholesterol, total cholesterol, apolipoprotein B, and triglycerides in adults with high cholesterol or mixed dyslipidemia. It is also approved for heterozygous familial hypercholesterolemia in adults and children as young as 8. Some clinicians also prescribe it off-label for primary prevention of atherosclerotic cardiovascular disease.
Adults with primary hyperlipidemia or mixed dyslipidemia
Adults with heterozygous FH
Children 8+ with heterozygous FH
Off-label: primary ASCVD prevention
Leqvio vs. Livalo Pros and Cons
Leqvio
Leqvio's twice-yearly dosing after the first two injections makes it appealing for patients who struggle with daily pills or want fewer touchpoints with their treatment. It must be given by a healthcare provider, and coverage can be inconsistent since it is a newer, costlier therapy.
Pros
Only 2 doses in year one, then 1 injection every 6 months
Avoids daily pill burden entirely
Different mechanism than statins, useful if statins aren't tolerated
Approved down to age 12 for familial hypercholesterolemia
Cons
Must be administered by a healthcare provider, not self-injected
No long-term cardiovascular outcomes data yet
Newer drug with less real-world safety history
Insurance approval can be difficult due to high cost
Livalo
Livalo has been used since 2009, giving prescribers decades of statin safety and outcomes data to draw on. It requires a daily pill and carries the familiar statin risks of muscle pain and liver enzyme changes, but has fewer drug interactions than many other statins.
Pros
Decades of statin safety and outcomes data
Minimal CYP3A4 metabolism means fewer drug interactions
Taken and adjusted at home without office visits
Approved for children as young as 8 with familial hypercholesterolemia
Cons
Requires taking a pill every single day
Carries statin risks of myopathy and rare rhabdomyolysis
Contraindicated with cyclosporine and active liver disease
No generic version currently available, unlike most statins
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.